The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Launched by GUANGZHOU YIPINHONG PHARMACEUTICAL CO.,LTD · Dec 3, 2015

Keywords

ClinConnect Summary

Treatment group: Fuganlin Oral Liquid 10mL. Control group: Xiaoer Jiebiao oral liquid 100mL. Treatment for one week. Patients who were recovered within one week can withdrawal at any time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed as acute upper respiratory infection.
• • 2. Patients with Traditional Chinese Medicine syndrome of qi deficiency and wind-heat.
• • 3. Patients aged 1 to 12 years.
• • 4. With course of disease in 48 hours or less.
• • 5. Signed informed consent by a Parent or legal guardians.
• Exclusion Criteria:
• • 1. Patients diagnosed as tonsillitis, bronchitis, bronchiolitis, pneumonia;
• • 2. Patients have a history of hyperpyretic convulsion;
• • 3. Severe malnutrition, rickets patients and merge the heart, brain, liver, kidney and hematopoietic system and other serious primary diseases;
• • 4. The increased of serum creatinine (Cr), blood urea nitrogen (BUN), alanine aminotransferase (ALT), and urinary protein, urine RBC above "+", which can not use the test illness or possibly combined disease conditions to explain;
• • 5. Patients with allergic physique (Allergic to above two kinds of substance), allergic to the composition of the preparation or control drug;
• • 6. According to the doctors' determination,likely to loss to follow up.